NCT00198055 - A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Asperger's DisorderPervasive Developmental Disorder

Interventions

DRUG

aripiprazole

Aripiprazole 5 mg per day for 2 weeks, then can be increased to 10mg per day if tolerated for 2 weeks, then can be increased to 15 mg per day for 4 weeks.

Trial Locations (1)

46020

Riley Hospital, Riley Child and Adolescent Psychiatry Clinic, Indianapolis